Last viewed: AMGN


Prices are updated after-hours



nasdaq:AMGN Amgen Inc.

AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (5.8% 1m) (-7.3% 1y) (0.0% 2d) (-0.1% 3d) (1.2% 7d) (NaN% volume)
http://www.amgen.com
Sec Filling | Patents | 23400 employees

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

add to today's watch list email alert is off




brands  

Press-releases


Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
Published: 2022-01-20 (Crawled : 14:00) - prnewswire.com
JNJ | News | $167.165 | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.0% C: 0.0%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -1.78% H: 0.0% C: 0.0%
BAX | News | $85.99 | twitter stocktwits trandingview |
Health Technology
| | O: -0.29% H: 0.0% C: 0.0%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.0% H: 0.0% C: 0.0%

drug research cancer
LUMAKRAS® (sotorasib) Receives Approval In Japan For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published: 2022-01-20 (Crawled : 11:00) - biospace.com/
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.0% H: 0.0% C: 0.0%
BGNE | News | $238.55 | twitter stocktwits trandingview |
Health Technology
| | O: 3.75% H: 0.0% C: 0.0%

lumakras approval cel lung cancer cancer
Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.0% C: 0.0%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%
GLAXF | News | $22.5865 | twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.22% C: -1.8%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: 0.0%

era therapeutics growth
Osteoporosis Drugs Market - 38% of Growth to Originate from North America |Antiresorptive Drugs Segment to be Significant for Revenue Generation | 17000+ Technavio Reports
Published: 2022-01-18 (Crawled : 17:00) - prnewswire.com
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 0.0% C: 0.0%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: 1.4% H: 0.0% C: 0.0%

america era drug report growth osteoporosis
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.Industry Executive Brings More than 20 Years of Clinical Drug Development Expertise
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
IMRX | $12.32 | twitter stocktwits trandingview |
| | O: 0.85% H: 3.81% C: -5.42%
BPMC | News | $72.51 | twitter stocktwits trandingview |
Health Technology
| | O: -1.6% H: 0.99% C: -4.69%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: 1.4% H: 0.0% C: 0.0%
ZYME | $13.46 | twitter stocktwits trandingview |
Health Technology
| | O: -0.87% H: 1.21% C: -9.77%

drug
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
LLY | News | $245.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
AMRX | $4.46 | twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.0% C: 0.0%
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 0.0% C: 0.0%
GILD | News | $70.28 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
GLAXF | News | $22.5865 | twitter stocktwits trandingview |
Health Technology
| | O: -1.67% H: 3.62% C: 3.62%
PPG | $162.57 | twitter stocktwits trandingview |
Process Industries
| | O: -2.07% H: 0.0% C: 0.0%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
PHAT | $14.8 | twitter stocktwits trandingview |
Health Technology
| | O: -3.08% H: 0.0% C: 0.0%
JNJ | News | $167.165 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%

space spac
BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation
Published: 2022-01-13 (Crawled : 12:30) - globenewswire.com
BBIO | $11.7 | twitter stocktwits trandingview |
Health Technology
| | O: -5.11% H: 1.25% C: -4.2%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: 0.0%

bbp-398 lumakras solid tumors ces potential collaboration
PD-1 And PD-L1 Inhibitors Market to Grow by USD 29.97 billion| Reduction in Cancer Mortality Rate to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-01-13 (Crawled : 11:00) - prnewswire.com
AGEN | $2.84 | twitter stocktwits trandingview |
Health Technology
| | O: -2.28% H: 1.67% C: -3.67%
AZN | News | $59.69 | twitter stocktwits trandingview |
Health Technology
| | O: 1.0% H: 0.02% C: -0.99%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: 0.0%
AZNCF | News | $119.67 | twitter stocktwits trandingview |
Health Technology
| | O: 2.17% H: 0.07% C: -0.53%

research cancer growth
TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMA
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: 0.0%
BGNE | News | $238.55 | twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.08% C: -5.65%

treatment
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
MDT | News | $107.38 | twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 0.0% C: 0.0%
SNY | News 2 d | $51.79 | twitter stocktwits trandingview |
Health Technology
| | O: 1.58% H: 0.0% C: 0.0%
GLAXF | News | $22.5865 | twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.0% C: 0.0%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: 0.71% H: 0.0% C: 0.0%
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%
SNYNF | News 2 d | $104.92 | twitter stocktwits trandingview |
Health Technology
| | O: -3.41% H: 5.99% C: 1.1%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%
BMY | $64.72 | twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.0% C: 0.0%


See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001127602-21-023488 4 2021-08-10 Buy A 760 935


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying